AI-Designed Personalized mRNA Therapy Cuts Melanoma Recurrence Risk
An AI-designed personalized mRNA therapy has reduced melanoma recurrence, metastasis and death, BioXconomy reports; effect sizes and trial details remain unstated.
Topic
Personalized Cancer Vaccine
Topic
Personalized Cancer Vaccine
Evaxion to Present New EVX-01 Immune Data at SITC 2026
Evaxion will present comprehensive immune profiling of EVX-01 plus pembrolizumab at SITC on Nov. 6–7, after a 75% two-year ORR in…